BA
63
5
HIG
52
-4
NDAQ
52
2
MHK
34
-2
PEP
47
3
ADSK
65
-3
SYY
50
-3
SCHW
64
3
DVN
18
-3
SYF
83
-5
ABT
56
2
DAL
62
-2
DLTR
54
3
TMO
56
-2
FRT
39
-4
ZBH
60
-2
WFC
65
-3
ORCL
59
-3
PAYX
50
3
MRK
30
-8
BA
63
5
HIG
52
-4
NDAQ
52
2
MHK
34
-2
PEP
47
3
ADSK
65
-3
SYY
50
-3
SCHW
64
3
DVN
18
-3
SYF
83
-5
ABT
56
2
DAL
62
-2
DLTR
54
3
TMO
56
-2
FRT
39
-4
ZBH
60
-2
WFC
65
-3
ORCL
59
-3
PAYX
50
3
MRK
30
-8
Financhill
Back

Serina Therapeutics 10K Form

Sell
46

SER
Serina Therapeutics

Last Price:
4.80
Seasonality Move:
3.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SER News And Ratings

See the #1 stock for the next 7 days that we like better than SER

SER Financial Statistics

Sales & Book Value

Annual Sales: $500K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

EPS (TTM): 0.11880
Net Income (TTM): $1.19M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Serina Therapeutics Earnings Forecast

Key Serina Therapeutics Financial Ratios

  • The Research & Development expenses have been 314.62% of Revenue.
  • The Interest Expense is -0.59% of Operating Income.
  • The Net Earning history of SER is -536.42% of Total Revenues.
  • Per Share Earnings over the last 2 years have been positive in 0 years.

Serina Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: SER
Website: serinatherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SER Technical Analysis vs Fundamental Analysis

Sell
46
Serina Therapeutics (SER) is a Sell

Is Serina Therapeutics a Buy or a Sell?